This prospective, open label, uncontrolled study was performed to evaluate the efficacy and tolerability of the modified Atkins diet in children with refractory infantile spasms. Fifteen consecutive children aged six months to three years having daily infantile spasms in clusters with electroencephalographic evidence of hypsarrhythmia despite treatment with hormonal treatment (oral corticosteroids/ adrenocorticotrophic hormone) and/or vigabatrin, and at least one additional anti-epileptic drug were enrolled. Children with known or suspected inborn errors of metabolism or systemic illnesses were excluded. Carbohydrate intake was restricted to ten grams/day. Among these 12 boys and three girls (median age-24 months), 13 had symptomatic etiology. After three months of diet, six children were spasm free. The time to spasm freedom after diet initiation ranged from two days to two months. The most frequent adverse effect observed was constipation. The modified Atkins diet was found to be effective and well tolerated in children with refractory infantile spasms (ClinicalTrials.gov identifier: NCT01006811).
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cluster per day with electroencephalographic evidence of hypsarrhythmia or its variants and failure of hormonal treatment (oral corticosteroids/adrenocorticotrophic hormone) and/or vigabatrin, and at least one more anti-epileptic drug were enrolled. Children with known or suspected inborn errors of metabolism as evidenced by: 2 or more of the following: a history of parental consanguinity, prior affected siblings, unexplained vomiting, intermittent worsening of symptoms, recurrent episodes of lethargy, altered sensorium, or ataxia, hepatosplenomegaly on examination And/or 2 or more of the following biochemical abnormalities high blood ammonia (>80 mmol/L), high arterial lactate (>2 mmol/L), metabolic acidosis (pH <7.2), hypoglycaemia (blood sugar <40 mg/dl), abnormal urinary aminoacidogram, presence of reducing sugars or ketones in urine, and positive results on urine neurometabolic screening were excluded. Children from families with motivational issues likely to affect compliance and those with systemic illness were also excluded. Because of the exploratory nature of this trial, we planned a convenience sample of 15 consecutive patients.
Pre-diet preparation
During a two week period, baseline clinical evaluation was done. Parents were educated to note the frequency of clusters and spasms and maintain seizure logs. Medications were changed to carbohydrate free preparations. ACTH or corticosteroids were tapered off two weeks before starting the diet.
Modified Atkins diet administration
Carbohydrate intake was restricted to 10 g/day. Carbohydrate content of various food items was explained to the parents, and exchange lists were provided. Fat intake (e.g. cream, butter, oils, ghee) was actively encouraged and protein intake was not restricted. A list of recipes based on common locally available foods was provided. For the younger infants not started on semisolid food, a liquid diet based on milk, soya-milk, cream and oil was explained, Each child also received a sugar-free, fat soluble vitamin supplement and calcium supplementation. The antiepileptic drugs were continued unchanged during the three month study period. Parents were asked to check urine ketones by reagent sticks daily for the first week on the diet and twice weekly thereafter.
Follow up
Follow up was scheduled for two weeks, one, two and three months after diet initiation. Weight and urine ketones by reagent strips were checked at each visit. For children found to have nil or trace ketones, the child's diet records were reviewed with the family. If the need arose the family was re-explained the diet. Spasm frequency was checked according to parental reports and seizure logs. A sleep and a short awake EEG record was repeated in those who were seizure free or had a change in seizure type. The primary outcome measure was the proportion of children with spasm freedom for at least 15 days, three months after diet initiation. All adverse events during the diet were noted as per parental reports. 
Results
Nineteen children met the inclusion criteria. Four were excluded from the trial; three because of motivational issues in family and one because of suspected inborn error of metabolism. Of the fifteen children enrolled for the study, 12 were boys. In two children, spasms were cryptogenic, and in the rest they were symptomatic. Perinatal brain injury was present in 8 of the 13 children with symptomatic etiology (Table 1 ). All the children had co-morbid global developmental delay, while 13 had cerebral palsy. ACTH had been tried in 11 patients, oral prednisolone in 5 patients, and vigabatrin in 12 patients. Nine patients had failed trial of both ACTH and vigabatrin. Other drugs which had been tried included topiramate, sodium valproate, levetiracetam, zonisamide and benzodiazepines.
At three months after starting the diet, six patients (40%) were free of spasms. The median time from the initiation of diet to the last witnessed spasm was six days (range 2-60 days). There was electroencephalographic resolution of hypsarrhythmia in all these children. None of these children developed other seizure types. In one child spasms subsided but myoclonic jerks (2-3/week) continued. His EEG showed resolution of hypsarrhythmia but persistent multifocal interictal epileptiform discharges. Additionally, three children had a more than 50% reductions in spasm clusters. Four patients had no response at all, and the diet was discontinued at one month in two of these children, and at six weeks and two months in one child each. At six months follow up, nine patients were still on the diet. Out of these, six were spasm free, and three had more than 90% reduction in spasms. In addition to spasm freedom, parents have also reported improved alertness and interaction in all diet responsive children.
Constipation was the most frequent side effect, seen in six children. Four children experienced lethargy. Two children experienced recurrent chest infections, and one child had recurrent episodes of intercurrent febrile illnesses. One child lost weight on the diet, his weight for age dropped from the 50th to the 15th centile as per the WHO Child Growth standards. Reasons for discontinuation of the diet included lack of efficacy in four children, and development of recurrent chest infections in two children. At the two week spot check test, 11 patients had moderate and large urinary ketosis, while 4 children had small (one), trace (one) or absent urinary ketones (two).
Discussion
Traditionally the modified Atkins diet has been considered for use in older children, adolescents and adults as it is less restrictive than ketogenic diet. However, the modified Atkins diet may offer some benefits over ketogenic diet even in young children. Apart from outpatient initiation and ease of administration, children on this diet may experience fewer growth problems as proteins are not restricted. This diet is also ideal for resource-constraint settings with paucity of trained dieticians. 17 It does not require strict weighing of foods and is thus easier for parents to administer. The preponderance of males in our study possibly reflects the gender bias for referral, in our society. A 40% rate of spasm resolution at three months in our study was encouraging and comparable to the outcomes reported with KD. Kossoff et al. 6 reported spasm freedom in three out of 21 children (14%), while Eun et al. 7 reported spasm freedom in 15 out of 43 children (35%) at three months. In a large series of 104 children with infantile spasms treated with the ketogenic diet, spasm freedom was seen in 18% of the patients at 3 months and 28% at 6 months on the diet. These outcomes are better than those for newer drugs such as topiramate (17%) 2 and levetiracetam (11%). 3 In our study the diet was well tolerated by young children. Constipation was managed with lactulose. The development of frequent chest infections in two children was possibly due to exacerbation of underlying gastro-esophageal reflux. This has been reported with the KD as well. Two children did not develop urinary ketosis. The carbohydrate limit of 10 g/day was perhaps too high for these children. Perhaps the fat content in the diet needs to be increased along with a reduction in the carbohydrate limits in young children who do not develop ketosis. Adherence to the diet was not problematic, in patients in whom the spasms were controlled. Two patients discontinued the diet because of adverse effects. The results of our study need to be interpreted keeping in mind the drawbacks of uncontrolled small sample studies. The possibility of spontaneous resolution of spasms with time cannot be excluded. The use of parental reporting of seizures as the primary outcome measure also has inherent limitations. Long term video-EEG documentation would have been ideal to assess response. Despite these limitations we found the modified Atkins diet to be a feasible, effective and well tolerated in children with refractory infantile spasms. Further studies are needed to compare the efficacy of this therapy with other treatments such as the ketogenic diet and newer anticonvulsants, and also as treatment for new onset infantile spasms.
